Yılmaz, Y. And Eren, F. 2011. Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?". Metabolism: Clinical and Experimental , vol.60 .

Yılmaz, Y., & Eren, F., (2011). Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?". Metabolism: Clinical and Experimental , vol.60.

Yılmaz, YUSUF, And Fatih Eren. "Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?"," Metabolism: Clinical and Experimental , vol.60, 2011

Yılmaz, YUSUF And Eren, Fatih. "Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?"." Metabolism: Clinical and Experimental , vol.60, 2011

Yılmaz, Y. And Eren, F. (2011) . "Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?"." Metabolism: Clinical and Experimental , vol.60.

@article{article, author={YUSUF YILMAZ And author={Fatih Eren}, title={Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?"}, journal={Metabolism: Clinical and Experimental}, year=2011}